ARSENAULT KAITLYN
SEC CIK 1877242 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | CFO | 167.5K | — | $432.4K | 7 | 2021-12-14 | 2024-11-15 |
Most active insiders at SKYE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | 5AM Partners VII, LLC | 10% | — | $444.6K |
| 2 | Schwab Andrew J. | Dir, 10% | — | $444.6K |
| 3 | DHILLON PUNIT | CEO, Dir | — | — |
ARSENAULT KAITLYN made no open-market trades at SKYE in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2025-02-28 | 2024-11-15+ | SKYE | Skye Bioscience, Inc. | ARSENAULT KAITLYN | CFO | S - Sale | $4.99 | -43.2K | 167.5K | -21% | -$215.8K |
| M | 2024-11-19 | 2024-11-15+ | SKYE | Skye Bioscience, Inc. | ARSENAULT KAITLYN | CFO | S - Sale | $4.99 | -43.4K | 166.3K | -21% | -$216.7K |
| DA | 2024-03-04 | 2024-02-29 | SKYE | Skye Bioscience, Inc. | ARSENAULT KAITLYN | CFO | A - Grant | $0.00 | +25.0K | 209.7K | +14% | $0 |
| D | 2024-03-01 | 2024-02-29 | SKYE | Skye Bioscience, Inc. | ARSENAULT KAITLYN | CFO | A - Grant | $0.00 | +25.0K | 210.7K | +13% | $0 |
| D | 2023-11-06 | 2023-11-06 | SKYE | Skye Bioscience, Inc. | ARSENAULT KAITLYN | CFO | A - Grant | $0.00 | +128.2K | 185.7K | +223% | $0 |
| D | 2023-08-29 | 2023-08-25 | SKYE | Skye Bioscience, Inc. | ARSENAULT KAITLYN | CFO | A - Grant | $0.00 | +13.38M | 14.38M | +1,338% | $0 |
| D | 2021-12-16 | 2021-12-14 | SKYE | Skye Bioscience, Inc. | Arsenault Kaitlyn Melanie | CFO | A - Grant | — | +1.00M | 1.00M | New | — |
Purchase Sale Sale after option exercise All abbreviations